|
Tislelizumab, paclitaxel, Carboplatin Clinical Trials
1 actively recruiting trial
Pipeline
Phase 2/3: 1
Top Sponsors
- Second Affiliated Hospital of Nanchang University1
Indications
- Lung Cancer1
- Non Small Cell Lung Cancer1
- Cancer1
Other1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.